Rare NRG1 Fusion Market to Register Tremendous Growth at a
The dynamics of the rare NRG1 fusion market are anticipated to change in the coming years owing to the improvement in the research and development...
Source: globenewswire.com
Hummingbird Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hummingbird Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hummingbird Bioscience Today - Breaking & Trending Today
Imperative to find the right cancer patients who respond to specific medicines: Analyst
CNA’s Syahida Othman is at Singapore Week of Innovation and Technology where she spoke to Dr Lisa Ooi, Senior Vice President of Strategy of the Hummingbird Bioscience, a Singapore-based biotech company. Dr Ooi argues that with the vast data involved in precision medicine, AI helps to probe and pull out the right insi
Source: channelnewsasia.com
Why The Next Blockbuster Therapy May Come Out Of Singapore
Singapore's recruitment of talent, billions in investment, top universities, and attraction of venture capital makes it an exciting emerging hub for biotech innovation.
Source: forbes.com
Guest Post: Twenty years in, Singapore still searches for its biotech success story
In 2000, the Singapore government laid out $2b over five years as part of an initial push to catapult into a biotech hub.
Source: dealstreetasia.com
AbbVie ditches license option for Harpoon's TriTAC multiple myeloma program
Going forward, Harpoon said the TriTAC multiple myeloma program will remain exclusively within the company as it plans to complete an ongoing Phase 1 clinical trial with data to support the next phase of development.
Source: mmm-online.com